BSE Live
Aug 17, 16:01Prev. Close
292.00
Open Price
295.00
Bid Price (Qty.)
293.70 (10)
Offer Price (Qty.)
293.85 (2)
NSE Live
Aug 17, 16:04Prev. Close
292.25
Open Price
295.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
293.65 (4947)
Quarterly Results of Fortis Healthcare (in Rs. Cr.) | Jun '22 | Mar '22 | Dec '21 | Sep '21 | Jun '21 | |
Net Sales/Income from operations | 1,487.85 | 1,378.10 | 1,466.65 | 1,462.54 | 1,410.31 | |
Other Operating Income | -- | -- | -- | -- | -- | |
Total Income From Operations | 1,487.85 | 1,378.10 | 1,466.65 | 1,462.54 | 1,410.31 | |
EXPENDITURE | ||||||
Consumption of Raw Materials | -- | -- | -- | -- | -- | |
Purchase of Traded Goods | 346.51 | 332.74 | 333.90 | 339.74 | 396.99 | |
Increase/Decrease in Stocks | 2.65 | -9.58 | -0.27 | 11.10 | -47.39 | |
Power & Fuel | -- | -- | -- | -- | -- | |
Employees Cost | 255.27 | 237.88 | 251.10 | 235.66 | 248.30 | |
Depreciation | 74.29 | 77.28 | 76.11 | 74.54 | 72.91 | |
Excise Duty | -- | -- | -- | -- | -- | |
Admin. And Selling Expenses | -- | -- | -- | -- | -- | |
R & D Expenses | -- | -- | -- | -- | -- | |
Provisions And Contingencies | -- | -- | -- | -- | -- | |
Exp. Capitalised | -- | -- | -- | -- | -- | |
Other Expenses | 632.32 | 595.83 | 594.99 | 591.69 | 537.16 | |
P/L Before Other Inc., Int., Excpt. Items & Tax | 176.81 | 143.95 | 210.82 | 209.81 | 202.34 | |
Other Income | 20.70 | 5.99 | 6.69 | 8.02 | 7.84 | |
P/L Before Int., Excpt. Items & Tax | 197.51 | 149.94 | 217.51 | 217.83 | 210.18 | |
Interest | 31.20 | 30.02 | 38.06 | 40.34 | 38.43 | |
P/L Before Exceptional Items & Tax | 166.31 | 119.92 | 179.45 | 177.49 | 171.75 | |
Exceptional Items | -- | 0.20 | 8.39 | 0.30 | 306.14 | |
P/L Before Tax | 166.31 | 120.12 | 187.84 | 177.79 | 477.89 | |
Tax | 42.02 | 39.42 | 51.21 | 51.43 | 55.78 | |
P/L After Tax from Ordinary Activities | 124.29 | 80.70 | 136.63 | 126.36 | 422.11 | |
Prior Year Adjustments | -- | -- | -- | -- | -- | |
Extra Ordinary Items | -- | -- | -- | -- | -- | |
Net Profit/(Loss) For the Period | 124.29 | 80.70 | 136.63 | 126.36 | 422.11 | |
Minority Interest | -12.06 | -19.06 | -24.97 | -23.74 | -167.06 | |
Share Of P/L Of Associates | 10.02 | 6.33 | 5.08 | 4.24 | 8.50 | |
Net P/L After M.I & Associates | 122.25 | 67.97 | 116.74 | 106.86 | 263.55 | |
Equity Share Capital | 754.96 | 754.96 | 754.96 | 754.96 | 754.96 | |
Reserves Excluding Revaluation Reserves | -- | -- | -- | -- | -- | |
Equity Dividend Rate (%) | -- | -- | -- | -- | -- | |
EPS Before Extra Ordinary | ||||||
Basic EPS | 1.62 | 0.90 | 1.55 | 1.42 | 3.49 | |
Diluted EPS | 1.62 | 0.90 | 1.55 | 1.42 | 3.49 | |
EPS After Extra Ordinary | ||||||
Basic EPS. | 1.62 | 0.90 | 1.55 | 1.42 | 3.49 | |
Diluted EPS. | 1.62 | 0.90 | 1.55 | 1.42 | 3.49 | |
Public Share Holding | ||||||
No Of Shares (Crores) | -- | -- | -- | -- | -- | |
Share Holding (%) | -- | -- | -- | -- | -- | |
Promoters and Promoter Group Shareholding | ||||||
a) Pledged/Encumbered | ||||||
- Number of shares (Crores) | -- | -- | -- | -- | -- | |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
- Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |
b) Non-encumbered | ||||||
- Number of shares (Crores). | -- | -- | -- | -- | -- | |
- Per. of shares (as a % of the total sh. of prom. and promoter group). | -- | -- | -- | -- | -- | |
- Per. of shares (as a % of the total Share Cap. of the company). | -- | -- | -- | -- | -- |
10.08.2022
Buy Fortis Healthcare; target of Rs 330: Prabhudas Lilladher
06.08.2022
Fortis Health Consolidated June 2022 Net Sales at Rs 1,487.85 crore, up 5.5% Y-o-Y
06.08.2022
Fortis Health Standalone June 2022 Net Sales at Rs 247.15 crore, up 21.44% Y-o-Y
08.07.2022
Fortis Healthcare Q1 PAT may dip 58.3% YoY to Rs 109.8 cr: Prabhudas Lilladher
06.08.2022
Fortis Health Consolidated June 2022 Net Sales at Rs 1,487.85 crore, up 5.5% Y-o-Y
06.08.2022
Fortis Health Standalone June 2022 Net Sales at Rs 247.15 crore, up 21.44% Y-o-Y
26.05.2022
Fortis Health Consolidated March 2022 Net Sales at Rs 1,378.10 crore, up 10.03% Y-o-Y
26.05.2022
Fortis Health Standalone March 2022 Net Sales at Rs 210.26 crore, up 7.93% Y-o-Y